MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung-Reference-Cited by-同舟云学术

MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

Published:2017-03-21 Issue:26 Volume:8 Page:42428-42437
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Saffroy Raphaël¹²,Fallet Vincent³⁴,Girard Nicolas⁵,Mazieres Julien⁶,Sibilot Denis Moro⁷,Lantuejoul Sylvie⁸,Rouquette Isabelle⁹,Thivolet-Bejui Françoise¹⁰,Vieira Thibaut³⁴,Antoine Martine³¹¹,Cadranel Jacques³⁴,Lemoine Antoinette¹²,Wislez Marie³⁴

Affiliation:

1. Department of Biochemistry and Oncogenetics, AP-HP Hôpital Paul-Brousse, Hôpitaux Universitaire Paris Sud, Villejuif, France

2. UMR-S 1193, Univ Paris-Sud, Université Paris-Saclay, Villejuif, France

3. GRC n°04, Theranoscan, Sorbonne Universités, UPMC Univ Paris 06, Paris, France

4. Pulmonary Medicine Unit, AP-HP, GH HUEP, Hôpital Tenon, Paris, France

5. Respiratory Medicine, Thoracic Oncology Group, Groupement Hospitalier Est, Hospices Civils de Lyon, Lyon, France

6. Pulmonary medicine Unit, Hôpital Larrey, Centre Hospitalier Universitaire, Toulouse, France

7. Thoracic Oncology Unit, PTV, CHU Grenoble Alpes, Grenoble, France

8. Department of Pathology, Hôpital A. Michallon, Centre Hospitalier Universitaire, Grenoble, France

9. Centre Hospitalier Universitaire Rangueil, Service d’anatomie Pathologique, Toulouse, France

10. Department of Pathology, Hôpital Louis Pradel, Lyon, France

11. Department of Pathology, AP-HP, GH HUEP, Hôpital Tenon, Paris, France

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma;Discover Oncology;2024-08-29

2. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real‐world cohort analysis;The Journal of Pathology: Clinical Research;2024-04-25

3. Chinese expert consensus on clinical practice of MET detection in non-small cell lung cancer;Therapeutic Advances in Medical Oncology;2024-01

4. The development of amivantamab for the treatment of non-small cell lung cancer;Respiratory Research;2023-10-25

5. Chemoresistance Mechanisms in Non-Small Cell Lung Cancer—Opportunities for Drug Repurposing;Applied Biochemistry and Biotechnology;2023-09-18